Award

Helix Biotech Biosimilar mRNA Vaccines

UK HEALTH SECURITY AGENCY

This public procurement record has 2 releases in its history.

TenderCancellation

04 Sep 2025 at 12:41

UK12 - Procurement Termination Notice
Award

12 Aug 2025 at 09:18

UK5 - Transparency Notice
Summary of the contracting process

The procurement process, led by the UK Health Security Agency, centred around the provision of biosimilar mRNA vaccines, specifically focusing on industry advancements in biotechnology. The buying organisation, a central government public authority, is located at 10 South Colonnade in London, United Kingdom. Initially, a direct award strategy was employed with Helix Biotech Inc., situated in Tennessee, USA. This direct procurement was chosen due to the unique capabilities of Helix Biotech in supplying vaccine mimic materials equivalent to existing licensed vaccines. The contract, awarded on 12th August 2025, is now in a completed status, although a tender cancellation notice was subsequently issued on 4th September 2025 to enable a revised transparency notice. The contract period is set from 8th September 2025 to 7th September 2027.

This tender represents a significant growth opportunity for businesses involved in the biosimilars and vaccine manufacturing sectors. Companies possessing innovative biotechnology solutions or those able to offer novel biopharmaceutical ingredients would find themselves particularly suited to compete in this sphere. Additionally, businesses with existing capabilities that include mRNA technology and lipid nanoparticle formulation are well positioned to take advantage of direct procurement methods employed by government entities, ensuring swift entry and operational benefits in this rapidly evolving industry. This contract underscores the potential for further collaborations with public health agencies looking to secure strategic resources aligned with contemporary health security needs.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Helix Biotech Biosimilar mRNA Vaccines

Notice Description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

Procurement Information

Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0585bd
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/053927-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
SME, VCSE
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£150,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
4 Sep 20255 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
12 Aug 20256 months ago
Contract Period
7 Sep 2025 - 7 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Cancelled
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK HEALTH SECURITY AGENCY
Additional Buyers

MISSING

Contact Name
Not specified
Contact Email
commercial.preparednessandcountermeasures@ukhsa.gov.uk
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Supplier Information

Number of Suppliers
1
Supplier Name

HELIX BIOTECH

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0585bd-2025-09-04T13:41:38+01:00",
    "date": "2025-09-04T13:41:38+01:00",
    "ocid": "ocds-h6vhtk-0585bd",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PBMQ-7576-DVGW",
            "name": "UK Health Security Agency",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBMQ-7576-DVGW"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "email": "commercial.preparednessandcountermeasures@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-PPON-PCMD-6995-GBGZ",
            "name": "Helix Biotech, Inc.",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PCMD-6995-GBGZ"
            },
            "address": {
                "streetAddress": "1460 Breda Drive",
                "locality": "Knoxville",
                "postalCode": "37918",
                "country": "US",
                "countryName": "United States",
                "region": "US"
            },
            "contactPoint": {
                "email": "info@helix-biotech.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme",
                "vcse": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBMQ-7576-DVGW",
        "name": "UK Health Security Agency"
    },
    "tender": {
        "id": "C371747",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Helix Biotech Biosimilar mRNA Vaccines",
        "description": "Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.",
        "lots": [
            {
                "id": "1",
                "status": "complete",
                "suitability": {
                    "sme": true,
                    "vcse": true
                }
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            },
            {
                "id": "053927-2025",
                "documentType": "tenderCancellationNotice",
                "noticeType": "UK12",
                "description": "Procurement termination notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/053927-2025",
                "datePublished": "2025-09-04T13:41:38+01:00",
                "format": "text/html"
            }
        ],
        "riskDetails": "A valid and current Cyber Essentials Certificate is required.",
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersTechnicalReasons"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Helix Biotech Biosimilar mRNA Vaccines",
            "status": "cancelled",
            "value": {
                "amountGross": 180000,
                "amount": 150000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-PPON-PCMD-6995-GBGZ",
                    "name": "Helix Biotech, Inc."
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33651600",
                            "description": "Vaccines"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2025-09-08T00:00:00+01:00",
                "endDate": "2027-09-07T23:59:59+01:00"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "047894-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/047894-2025",
                    "datePublished": "2025-08-12T10:18:36+01:00",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-09-01T23:59:59+01:00",
                    "status": "scheduled"
                }
            ],
            "statusDetails": "We are currently unable to modify the description on the Transparency Notice and therefore a termination notice has been issued for this procedure and a new UK5 Transparency Notice will be published with a modified description.",
            "finalStatusDate": "2025-09-02T00:00:00+01:00"
        }
    ],
    "language": "en"
}